Temple Lung Center: Advancing Research in ILD - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Temple Lung Center: Advancing Research in ILD

Interstitial lung diseases (ILD) significantly impact patient morbidity and mortality. As an ILD Center of Excellence, the Temple Lung Center has established comprehensive programs for the evaluation and management of patients with a wide range of ILDs. This includes extensive clinical research and lung transplantation expertise.

  • April 28, 2025

  • 2 min

Share

  • 1

    The Temple Lung Center specializes in the evaluation and management of various interstitial lung diseases (ILDs).

  • 2

    It is recognized as an ILD Center of Excellence, focusing on comprehensive patient care and clinical research.

  • 3

    The center has significant expertise in lung transplantation for patients with scleroderma and esophageal dysfunction.

  • 4

    Ongoing clinical trials at Temple Lung Center explore innovative therapies for conditions like idiopathic pulmonary fibrosis.

  • 5

    Patients can participate in trials at multiple clinical sites, with resources available for finding appropriate studies.

Original Source(s)

Temple Lung Center: Advancing Research in ILD

  • April 28, 2025

Related Content

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Organ Damage, BMI Linked to Fatigue in SLE

Cross-sectional study suggests fatigue is associated with damage accrual and body mass, not disease activity

Top 10 evidence-based essentials in pulmonology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice.